Saris­sa tight­ens its grip on Amarin as CEO re­signs

Saris­sa Cap­i­tal gained an­oth­er foothold in its takeover of Amarin with the de­par­ture of the Irish drug­mak­er’s CEO.

Amarin re­vealed Fri­day in an SEC fil­ing that Karim Mikhail re­signed as pres­i­dent and CEO ear­li­er this week. How­ev­er, there’s still an on­go­ing dis­pute be­tween Mikhail and Amarin, with the now ex-CEO in­sist­ing that he has a claim to sev­er­ance as a re­sult of his res­ig­na­tion. How­ev­er, Amarin says it dis­agrees and plans to dis­pute that claim.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN